PT71135B - Process for the manufacture of imidazolidine derivatives - Google Patents

Process for the manufacture of imidazolidine derivatives

Info

Publication number
PT71135B
PT71135B PT71135A PT7113580A PT71135B PT 71135 B PT71135 B PT 71135B PT 71135 A PT71135 A PT 71135A PT 7113580 A PT7113580 A PT 7113580A PT 71135 B PT71135 B PT 71135B
Authority
PT
Portugal
Prior art keywords
general formula
signifies
compound
see diagramm
manufacture
Prior art date
Application number
PT71135A
Other languages
English (en)
Portuguese (pt)
Other versions
PT71135A (en
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of PT71135A publication Critical patent/PT71135A/pt
Publication of PT71135B publication Critical patent/PT71135B/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/88Nitrogen atoms, e.g. allantoin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C275/30Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by halogen atoms, or by nitro or nitroso groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72Two oxygen atoms, e.g. hydantoin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72Two oxygen atoms, e.g. hydantoin
    • C07D233/80Two oxygen atoms, e.g. hydantoin with hetero atoms or acyl radicals directly attached to ring nitrogen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pyrrole Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Epoxy Resins (AREA)
PT71135A 1979-04-24 1980-04-23 Process for the manufacture of imidazolidine derivatives PT71135B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH383779 1979-04-24

Publications (2)

Publication Number Publication Date
PT71135A PT71135A (en) 1980-05-01
PT71135B true PT71135B (en) 1981-08-07

Family

ID=4264536

Family Applications (1)

Application Number Title Priority Date Filing Date
PT71135A PT71135B (en) 1979-04-24 1980-04-23 Process for the manufacture of imidazolidine derivatives

Country Status (13)

Country Link
EP (1) EP0017976B1 (cg-RX-API-DMAC7.html)
JP (1) JPS55143974A (cg-RX-API-DMAC7.html)
KR (1) KR850000719B1 (cg-RX-API-DMAC7.html)
AT (1) ATE3860T1 (cg-RX-API-DMAC7.html)
CA (1) CA1135706A (cg-RX-API-DMAC7.html)
DE (1) DE3063837D1 (cg-RX-API-DMAC7.html)
DK (1) DK174480A (cg-RX-API-DMAC7.html)
ES (1) ES490799A0 (cg-RX-API-DMAC7.html)
FI (1) FI801184A7 (cg-RX-API-DMAC7.html)
GR (1) GR67605B (cg-RX-API-DMAC7.html)
HU (1) HU184271B (cg-RX-API-DMAC7.html)
NO (1) NO801182L (cg-RX-API-DMAC7.html)
PT (1) PT71135B (cg-RX-API-DMAC7.html)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5411981A (en) * 1991-01-09 1995-05-02 Roussel Uclaf Phenylimidazolidines having antiandrogenic activity
USRE35956E (en) * 1991-01-09 1998-11-10 Roussel Uclaf Phenylimidazolidines having antiandrogenic activity
FR2724169B1 (fr) * 1994-09-06 1997-01-03 Roussel Uclaf Nouvelles phenylimidazolidines eventuellement substituees, leur procede et des intermediaires de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant
TW521073B (en) * 1994-01-05 2003-02-21 Hoechst Marion Roussel Inc New optionally substituted phenylimidazolidines, their preparation process, their use as anti-androgenic agent and the pharmaceutical compositions containing them
FR2715402B1 (fr) * 1994-01-05 1996-10-04 Roussel Uclaf Nouvelles phénylimidazolines éventuellement substituées, leur procédé et des intermédiaires de préparation, leur application comme médicaments et les compositions pharmaceutiques les renfermant.
CA2550447A1 (en) 2003-12-19 2005-07-07 The Regents Of The University Of California Methods and materials for assessing prostate cancer therapies
AU2005232526B2 (en) 2004-02-24 2011-06-23 The Regents Of The University Of California Methods and materials for assessing prostate cancer therapies and compounds
US7709517B2 (en) 2005-05-13 2010-05-04 The Regents Of The University Of California Diarylhydantoin compounds
LT2656842T (lt) 2006-03-27 2016-09-26 The Regents Of The University Of California Androgeno receptoriaus moduliatorius, skirtas prostatos vėžio ir su androgeno receptoriumi susijusių ligų gydymui
CN102755318B (zh) 2006-03-29 2014-09-10 加利福尼亚大学董事会 二芳基硫代乙内酰脲化合物
PE20121470A1 (es) 2007-10-26 2012-11-18 Univ California Compuestos de diarilhidantoina como antagonistas del receptor de androgeno
KR101819199B1 (ko) 2010-02-16 2018-01-16 아라곤 파마슈티컬스, 인코포레이티드 안드로겐 수용체 조절제 및 이의 용도
EA030128B1 (ru) 2012-09-26 2018-06-29 Арагон Фармасьютикалз, Инк. Способ лечения неметастатического кастрационно-резистентного рака простаты
JOP20200097A1 (ar) 2013-01-15 2017-06-16 Aragon Pharmaceuticals Inc معدل مستقبل أندروجين واستخداماته
TWI726969B (zh) 2016-01-11 2021-05-11 比利時商健生藥品公司 用作雄性激素受體拮抗劑之經取代之硫尿囊素衍生物
KR20240096623A (ko) 2017-10-16 2024-06-26 아라곤 파마슈티컬스, 인코포레이티드 비-전이성 거세-저항성 전립선암의 치료를 위한 항-안드로겐

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB997037A (en) * 1962-03-19 1965-06-30 Ici Ltd New hydrantoin derivatives
US3340070A (en) * 1963-08-23 1967-09-05 Shell Oil Co Artificial sweetening agent
FR2329276A1 (fr) * 1975-10-29 1977-05-27 Roussel Uclaf Nouvelles imidazolidines substituees, procede de preparation, application comme medicament et compositions les renfermant
MC1220A1 (fr) * 1977-10-28 1979-07-20 Hoffmann La Roche Nouveaux derives d'imidazolidine
CA1138334A (en) * 1977-10-28 1982-12-28 Karl Bernauer Pharmaceutical preparations containing certain urea derivatives

Also Published As

Publication number Publication date
EP0017976A2 (de) 1980-10-29
ATE3860T1 (de) 1983-07-15
EP0017976A3 (en) 1981-04-01
JPS55143974A (en) 1980-11-10
EP0017976B1 (de) 1983-06-22
DE3063837D1 (en) 1983-07-28
GR67605B (cg-RX-API-DMAC7.html) 1981-08-31
KR850000719B1 (ko) 1985-05-23
CA1135706A (en) 1982-11-16
DK174480A (da) 1980-10-25
HU184271B (en) 1984-07-30
ES8104243A1 (es) 1981-04-16
FI801184A7 (fi) 1981-01-01
NO801182L (no) 1980-10-27
KR830002722A (ko) 1983-05-30
PT71135A (en) 1980-05-01
ES490799A0 (es) 1981-04-16

Similar Documents

Publication Publication Date Title
GR67605B (cg-RX-API-DMAC7.html)
BG38639A3 (en) Method for preparing ester derivatives of 6- beta- hydroxymethylpenicillanic acid
BG41993A3 (en) Means and method for increase in cold resistance of plant cultures
AU1395283A (en) 1-carboxyalkanoylindoline-2-carboxylic acid esters
GR77088B (cg-RX-API-DMAC7.html)
HU179545B (en) Compositions for plant growth regulation containing phthalamide acid
FR2479813B1 (cg-RX-API-DMAC7.html)
ES465208A1 (es) Un procedimiento para preparar compuestos de imidazolina
ES8308870A1 (es) Procedimiento para la preparacion de derivados de acido 5-(4-fenil-1-piperidinil) metil-2,3-dihidro-2-oxo-1h-imidazol-4-carboxilico.
GB1276277A (en) 2-chloroethane-(thiono)-phosphonic acid amido compounds, processes for their preparation, and their use for the regulation of plant growth
FR2457275B1 (cg-RX-API-DMAC7.html)
AU567867B2 (en) 5(e)-13,14,18,18,19,19-hexahydro-6a-carbaprostaglandin 12 derivatives
ES8605529A1 (es) Procedimiento para la preparacion de acidos alfa-aminoal- quilfosfonicos y de acidos alfa-aminoalquilfosfinicos
IE44403L (en) CIS-4a-PHENYL-ISOQUINOLINES
GR70374B (cg-RX-API-DMAC7.html)
SE7701107L (sv) Biologiskt aktiva amider
ES479033A1 (es) Un procedimiento para la preparacion de derivados de n-iminometil piperidina.
LU88287I2 (fr) Cyproternacetate (Climen)
DE3264330D1 (en) Process for the preparation of cycloalkenon derivatives
BG34759A3 (bg) Метод за стабилизиране на хаюогениращи съединения
GB1526607A (en) Zearalin ethers
ES461718A1 (es) Procedimiento para la obtencion de composiciones herbicidas
EP0041576A4 (en) 1- (2,6-DICHLORPHENYL) -2-QUINOLINONE-IMIN-3-CARBOXYLIC ACID, PRODUCTION OF THE COMPOUND AND CONTAINING PAIN-RELIEFING, ANTI-FLAMMING COMPOSITION.
DE3062286D1 (en) 9-chloro-prednisolone derivatives, their preparation and their utilization
ES461037A1 (es) Un procedimiento para la preparacion de derivados tiofeno.